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Abstract. Hemophilia B, an X-linked recessive bleeding disorder, is caused by heterogeneous mutations in the factor IX (F9)
gene. Hence, carriers of the disease are usually detected by F9 gene linked RFLP analysis. We aimed to test a set of RFLP markers
(DdeI, XmnI, MnlI, TaqI & HhaI), used worldwide for carrier detection, to estimate its heterozygosity in different population
groups of India, and identify additional single nucleotide polymorphisms (SNPs) if necessary. A total of 8 population groups
encompassing different regions of India, consisting of 107 unrelated normal females without any history of hemophilia B in the
family and 13 unrelated obligate carriers were recruited in the study. Regions of F9 gene were amplified by PCR from genomic
DNA of the donors followed by restriction enzyme digestion and/or sequencing as appropriate. Combined informativeness for
the markers varied between 52–86% among normal females belonging to different geographical locations of India. Haplotype
analysis revealed that the most prevalent haplotype lacked the restriction sites for all five RFLP markers. Screening regions of
F9 gene that harbor 10 SNPs reported in dbSNP yielded only two SNPs, which increased the overall informativeness in each
population group and heterozygosity in the obligate carriers for the disease from 38% to 69%. Our data show that heterozygosity
of commonly used RFLP markers is remarkably variable across different regions of India. Thus prudent selection of the markers
based on specific population groups including usage of additional markers is recommended for efficient carrier detection.
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1. Introduction
Hemophilia B is an X-linked recessive bleeding
disorder affecting approximately 1 in 30,000 males
and caused by deficient clotting factor IX (FIX) ac-
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tivity [1]. FIX is a plasma thromboplastic compo-
nent and plays an important role in blood coagula-
tion cascade by activating factor X through interac-
tions with calcium, membrane phospholipids and ac-
tivated factor VIIIa by limited proteolysis [2]. Fac-
tor IX (F9) gene, located at Xq27, spans 33 kb of ge-
nomic DNA comprising 8 exons and encodes a 1.4 kb
mRNA [3]. The FIX coagulant activity and immunoas-
say results have considerable overlap between the lev-
els in carriers and normal women to unambiguously
establish the disease status. Several studies have re-
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vealed high mutational heterogeneity and a relatively
high rate of de novo mutations in F9 gene [4,5]. Over
500 mutations are recorded in the Hemophilia B muta-
tion database (http://www.kcl.ac.uk/ip/petergreen),and
strategies for identification of common mutations based
on the database analysis have also been reported [6].
Mutational heterogeneity has also been reported in In-
dian patients [7,8]. It is estimated that number of
hemophilia B patients in India is about 10,000 [9]. The
mutational heterogeneity and the inability of the im-
munoassay results to detect carriers necessitated an in-
direct approach for DNA based carrier analysis and
prenatal diagnosis in the affected families, which in-
volves tracking the mutant chromosome by analysis of
intragenic markers at hemophilia B locus. However,
this strategy fails if the markers are not informative
in the family members. In 1993, WHO published a
list of markers [10] for efficient carrier detection based
on early reports on high heterozygosity of these mark-
ers in Caucasian population. Although, limited studies
have reported these markers to be highly heterozygous
in western and north Indian population groups [9,11],
our initial studies on a mixed population from eastern
India indicated lower heterozygosity of these markers.
Therefore, we undertook this study to examine the het-
erozygosity of these markers in different population
groups across the country. We also report identifica-
tion of two new F9 polymorphisms with high levels of
heterozygosity, which improve the efficiency of carrier
detection for hemophilia B.
2. Materials and methods
2.1. Study population
A total of 107 unrelated normal females from eight
population groups were recruited in the study, which
included three ethnic groups (Brahmin, Mahishya and
Bagdi) and a mixed urban population from Kolkata,
West Bengal from eastern region, three ethnic groups
(Iyenger, Ulladan and Rajakoya) from Andhra Pradesh
in southern region, and one ethnic group (Garasias) and
a mixed urban population from Ahmedabad, Gujarat
from western region of the country (Table 1). Insti-
tutional ethics committee of respective institutes ap-
proved the study following the guidelines of Indian
Council of Medical Research, Govt. of India for han-
dling of human samples. Our study population also
contained 13 unrelated obligate carriers of Hemophilia
B recruited through Hemophilia Federation of India,
comprising eight from Eastern India (Kolkata chapter)
and five from Southern India (Chennai chapter). Blood
samples were collected from all these individuals after
obtaining their informed consent.
2.2. DNA analysis
Genomic DNA was isolated from each individual us-
ing the conventional phenol-chloroform method [12].
PCR was carried out in total volume of 25.0 µl contain-
ing 50–100 ng genomic DNA, 0.4 µM of each primer,
0.2 mM of each dNTP, 2.5 mM of MgCl2 and 0.5 unit of
Taq polymerase (Invitrogen, Carlsbad, CA). The RFLP
markers (DdeI, XmnI, MnlI, TaqI & HhaI) were ampli-
fied using primers as described in WHO bulletin (1994)
with a correction in the reverse primer for HhaI marker
(5’-AGATTTCAAGCTACCAACAT-3’ in place of 5’-
AAGTACCTGCCAAGGGAATTGACCTGG-3’). The
following conditions were used to amplify the region
of interest (markers): initial denaturation at 94◦C for
3 min, followed by 35 cycles of denaturation at 94 ◦C
for 30 s, annealing at 52–58◦C for 30 s (based on the
Tm of the primer pairs) and extension at 72◦C for 30 s,
and a final extension at 72◦C for 3 min. Aliquots of
5 µl of the PCR product were checked for amplification
and subjected to digestion using appropriate restriction
enzymes under the conditions described by the man-
ufacturer (New England Biolabs, Beverly, MA). The
DNA fragments in the digest were separated by elec-
trophoresis in polyacrylamide gel (6%) and visualized
under UV light after ethidium bromide staining.
To identify new SNP, segments of introns 3, 4 and
5 of F9 gene were amplified. The PCR products were
column purified using Quiagen PCR purification kits
(Qiagen, Hilden, Germany) and bi-directional sequenc-
ing was performed using an ABI prism 3100 DNA
sequencer with dye terminator chemistry. Nucleotide
changes were detected by identifying double peaks in
the chromatogram due to heterozygosity of the DNA
sample. The sequences were analyzed using pairwise
BLAST [13] to identify any changes from the normal
sequences available in the database. Alteration of re-
striction site due to identified nucleotide variant was
examined by WEBCUTTER (http://www.firstmarket.
com/cutter/cut2.html). A SNP (A>C, rs422187) lo-
cated in intron 5 was found to generate a site for
Hpy188I and was analyzed by PCR-RFLP using primer
pair: 5’-GGTCCTGGTGAATATGGCTGTG-3’, and
5’-TACGGAAATAGAATAGGTGTTC-3’. However,
another SNP (C>T, rs392959) in intron 3, did not
alter any restriction site and was analyzed by di-
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Table 1
Population groups studied for heterozygosity of RFLP markers linked to hemophilia B locus
Region of India Population group Number of females
East Brahmin, Bagdi, Mahishya ethnic groups and
mixed population from Kolkata
69
West Garasias, mixed population from Ahmedabad 21
South Rajakoya, Iyenger and Ulladan 17
Study reported in Chowdhury et al. (2001) on ethnic groups of north Indian population has
been used for comparison with other regions of India.
Table 2
Allele frequency and heterozygosity of RFLP markers in Indian population groups
RFLP EAST (69) SOUTH (17) WEST (21) NORTH (28)*
+ − Heterozygosity + − Heterozygosity + − Heterozygosity Heterozygosity
Exp. Obs. Exp. Obs. Exp Obs Obs
DdeI 0.086 0.928 0.134 0.145 0.118 0.882 0.208 0.235 0.310 0.690 0.427 0.476 0.50
TaqI 0.200 0.8 0.296 0.260 0.118 0.882 0.208 0.235 0.261 0.739 0.385 0.238 NA
Xmn 1 0.071 0.929 0.194 0.188 0 1.000 – 0 0.238 0.762 0.367 0.190 0.23
Mnl 1 0.114 0.886 0.238 0.217 0.118 0.882 0.208 0.235 0.214 0.786 0.336 0.330 NA
Hha 1 0.100 0.9 0.182 0.203 0.235 0.765 0.3595 0.470 0.190 0.810 0.308 0.380 0.46
Hpy188I 0.157 0.842 0.267 0.232 0.176 0.835 0.294 0.352 0.175 0.825 0.288 0.333 NA
∗Refers to a separate study from North India (Chowdhury et al. 2001); NA, Not available.
Note: Figures in the parentheses refer to the number of female samples taken from each population. In case of Southern India, with lowest
number of female donors, we also examined 73 males for the same set of markers and observed similar frequencies except for HhaI (0.123 vs
0.235).
rect sequencing of the amplicon generated using the
primer pair 5’-GTCTCTTGTTGTATTTGACCCCA-
3’ and 5’-GTCAGAATGAGAAGGGAATC-3’.
2.3. Statistical analysis
The allele frequency for each marker was calculated
using the allele counting method, which was then used
to estimate the expected heterozygosity. Haplotype
frequencies and linkage disequilibrium between dif-
ferent markers were estimated following Expectation-
maximization algorithm using ARLEQUIN software
(version 2.1).
3. Results
To evaluate the utility of the commonly used RFLP
markers (DdeI, XmnI, TaqI, MnlI, HhaI) in F9 gene for
carrier detection, we first determined heterozygosity of
each marker in the selected population groups. Then,
relative and overall informativeness of these markers
was determined. Since the overall heterozygosity for
all five markers did not reach 100%, we also attempted
to identify markers with high heterozygosity in the F9
gene. Haplotype analysis was performed to find vari-
ation in chromosomes in each population group. Two
additional SNPs were identified which increased the
efficiency of hemophilia B carrier detection as demon-
strated by genotyping the obligate carriers.
3.1. Highly variable heterozygosity of RFLP markers
among population groups
The heterozygosity of the RFLP markers showed
remarkable heterogeneity among different population
groups of India (Table 2). While the XmnI RFLP was
completely monomorphic, HhaI proved to be the most
efficient marker in the southern group with a heterozy-
gosity of 0.47. One of the ethnic groups of south-
ern India (Ulladan), was observed to be completely
monomorphic for three RFLPs (TaqI, XmnI & MnlI)
(data not shown separately). Analysis of 73 males from
the Southern India revealed frequencies for the mark-
ers to be similar to the females from the same popu-
lation group despite relatively small number of indi-
viduals available for analysis. Similarly, the eastern
group also showed low heterozygosity for most of the
markers, with TaqI being the most efficient marker with
highest heterozygosity (0.26) followed by MnlI (0.22)
and HhaI (0.20). Compared to the eastern and south-
ern groups, the western group showed relatively higher
heterozygosity for all the markers, which is consistent
with the previous reports [9,11]. In this group, DdeI
was the most heterozygous marker (0.48) followed by
HhaI (0.38) and MnlI (0.33). Heterozygosity for these
markers has been reported to be quite high in the north
Indian population (Chowdhury et al., 2001). Since
we did not have any female sample from northern In-
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Fig. 1. Detection of SNP in intron 5. (A) Location of the SNP (A>C, rs422187) within F9 gene and the nature of the nucleotide change are
shown. The allelic difference resulting from the SNP was determined by Hpy188I digestion of the PCR product obtained using a pair of primers
selected from intron 5 of the gene. (B) Representative electropherogram showing the location of the SNP as a double peak in the heterozygous
condition (arrow). (C) 6% PAGE of PCR products from three representative samples and their genotype are shown. Lane M is pBS/HaeIII
digested DNA molecular weight marker. The size of the DNA molecular weight marker and the Hpy188I digested DNA fragments are shown on
the sides of the gel.
dia, we determined the allele frequencies of these five
markers in 30 male samples and also found them to
be relatively high (DdeI = 0.33, XmnI = 0.10, HhaI
= 0.172, 30 chromosomes) and comparable (DdeI =
0.40, XmnI = 0.18, HhaI = 0.36, 17 chromosomes)
to the reported study (Chowdhury et al., 2001). Three
of the commonly used markers (TaqI, XmnI and MnlI)
were observed to be in linkage disequilibrium in all
three population groups (p 0.002) except for northern
population where LD was observed between TaqI and
XmnI only (p = 0.001). The combined heterozygos-
ity for these markers was 52%, 59%, 86% for eastern,
southern and western Indian populations, respectively
(Fig. 2).
3.2. Estimation of heterozygosity for common RFLP
markers among obligate carriers for
hemophilia B
In addition to determining the heterozygosity of the
common RFLP markers in different population groups
in India, we calculated the heterozygosity of these
markers in 13 unrelated obligate carriers of hemophilia
B. Only 5 carriers (38%) were found to be heterozy-
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Fig. 2. Informativeness of the RFLP markers in different population groups of India. Panels A, B and C respectively represent the Eastern,
Southern and Western regions. RFLP markers analyzed in each bar diagram is denoted by DdeI (D), HhaI (Hh), Hpy188I (Hp), MnlI (M), TaqI
(T), and XmnI (X). Panel D shows informativeness for North India obtained from a separate study (Chowdhury et al. 2001). Informativeness for
each marker was calculated as the percentage of females heterozygous in each cluster.
gous using these five common RFLP markers. Despite
the fact that only a modest number of obligate carriers
were analyzed, the observation made based on studies
on normal individuals provides a wholesome picture on
the genomic variability in the hemophilia B locus.
3.3. Identification of new SNP markers and
assessment of their heterozygosity in various
population groups
We selected multiple regions of F9 gene harboring
at least 10 SNPs as recorded in dbSNP (www.ncbi.
nlm.nih.gov/SNP). Sequence analysis of these regions
from 35 normal unrelated females revealed only two
SNPs namely C>T in intron 3 (rs392959) and A>C
in intron 5 (rs422187) of F9. The first SNP did not
alter any restriction site and was scored in obligate
carriers by direct sequencing. Two obligate carriers,
homozygous for other markers, were heterozygous for
this SNP. For the lack of an easy format assay to score
the alleles, we did not estimate heterozygosity of this
marker in the normal population consisting of different
ethnic groups.
The second SNP (i.e. A>C in intron 5), however,
generated an Hpy188I restriction enzyme site. A
345 bp amplicon encompassing the Hpy188I site was
generated from genomic DNA, which would cleave into
two DNA fragments (220 bp and 125. bp) in the pres-
ence of the variant allele (Fig. 1). The heterozygosity
of this marker was observed to be fairly high across all
population groups (Table 2). The allele frequency of
the marker was also observed to be high in the group
of 30 males from northern India (0.416). Using this
marker, two additional obligate carriers for hemophilia
B were found to be heterozygous, thus increasing the
overall efficiency of carrier detection to 69% from the
existing 38% using the common RFLP markers.
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Table 3
Major haplotype frequencies in Indian population groups
S. No. Haplotypes East (69) South (17) West (21)
A 1 1 1 1 1 1 61.4% 69.6% 30.8%
B 1 1 1 1 2 1 4.2% 7.0% 8.4%
C 1 2 1 1 1 1 7.5% 0% 0%
D 1 2 2 2 1 1 0% 0% 15.0%
E 2 1 1 1 1 1 1.6% 3.7% 15.9%
F 2 1 1 1 2 1 1.5% 3.0% 7.4%
G 1 1 1 1 1 2 6.5% 3.3% 7.5%
Number in the parentheses refers to the number of female samples
taken from each population. Only those markers have been included
which have more than 5% frequency in any of the population groups.
Order of the markers: DdeI-TaqI-XmnI-MnlI-HhaI-Hpy188I. For
each RFLP locus allele 1 and allele 2 represent absence and presence
of the polymorphic restriction site, respectively.
3.4. Informativeness of the markers in the population
groups
To estimate the relative efficiency of each RFLP
marker and their collective efficiency for carrier de-
tection in different population groups, informativeness
of the markers was determined based on the heterozy-
gosity values. It was observed that in different pop-
ulations, the priority of choice of marker would vary
widely (Fig. 2). For example TaqI would be the marker
of choice for eastern India, but HhaI and DdeI would
be the markers to be used first for southern and west-
ern Indian groups respectively. We estimated that the
new marker (Hpy188I) would increase the informative-
ness marginally from 52% to 61%, 59% to 64% and
86% to 90% in eastern, southern and western groups,
respectively (Fig. 2). Two newly identified SNPs to-
gether were observed to increase the carrier detection
efficiency from 38% to 69% (5/13 to 9/13) among the
pool of obligate carriers. However, the increase in the
informativeness using the new markers in each popula-
tion group was only marginal.
3.5. Haplotype analysis
We estimated the number of major haplotypes and
the frequencies in each population group using the
RFLP markers. Thus, the genotypes at all six RFLP
markers were used to construct haplotypes of female
samples in each cluster (Table 3). Seven major haplo-
types, representing > 5% of chromosomes, were iden-
tified. The frequency of haplotype A, lacking restric-
tion site for all six RFLP varied from 60–70% among
the eastern and southern population groups, while the
western group had 31% of the same haplotype (Ta-
ble 3). Due to lack of female samples, north Indian
male samples were examined to identify the common
haplotypes and found to harbor 44.4% of the haplo-
type A. This observation suggested that the eastern and
southern population groups are likely to be less infor-
mative using the RFLP markers compared to the pop-
ulation groups from the northern and western part of
India.
4. Discussion
The prevalence of hemophilia B is similar worldwide
and the disease is caused by frequent de novo mutations
spanning throughout the F9 gene, which is 30–50% of
all patients [4,5].
For all practical purposes, the load of mutation in
the population cannot be eliminated but needs to be
controlled by mutation screening and carrier detection.
Although carrier analysis for relatively smaller gene
could be done by direct sequencing and is practiced
more with lowering the cost of large scale sequencing,
the strategy is not ideal for a wider use for diagnostic
purposes in developing countries with less resources
available for such endeavor. Hence carrier detection by
linkage analysis using informative markers is the best
alternative choice.
The PCR based RFLP markers commonly advocated
for use in carrier detection of hemophilia B were orig-
inally based on the studies primarily conducted on the
Caucasians. Subsequently, these markers have been
reported to have low heterozygosity in the Chinese [10,
14,15], Japanese [16,17] and Malay population [10].
Indians represent a large proportion of the world popu-
lation and the population genetic studies suggest mul-
tiple ethnic groups, which remain relatively isolated
through marriage within the community. Therefore, it
is likely that the polymorphic nucleotides in F9 gene
would have considerable variation in the entire coun-
try. In this context, our finding that the markers linked
to hemophilia B locus have variable informativeness
in different population groups is not unexpected. This
precise information,however, is important for informed
decision regarding marker selection for carrier detec-
tion in specific population group. Haplotype analysis
shows that a large proportion of the chromosome is
completely monomorphic for the five RFLP markers
commonly chosen for carrier analysis and underscores
importance of identification of new markers. Our at-
tempt to conduct the study on a larger sample size
was particularly challenging since only female sam-
ples were required to test heterozygosity of F9. Due
to socio- economic and cultural reasons, in many eth-
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nic groups, males are usually more easily available and
persuaded as the donors for blood collection in such
studies. Therefore, while studies involving a much
larger number of normal and carrier females would cer-
tainly be preferable, the present study clearly shows re-
markable difference in the informativeness of the mark-
ers studied and the results are consistent with previous
studies undertaken in some ethnic groups as mentioned
before.
Identification of new markers needs immense efforts
as our initial investigation identified only two out of 10
reported SNPs to be of use in carrier analysis. We did
not detect any novel SNP, but identified two SNPs sig-
nificantly increased the efficiency of the carrier detec-
tion. This observation is also consistent with the fact
that occurrence of polymorphism in X chromosome
is relatively rare [18]. Our observations highlight the
need to develop new markers with high heterozygos-
ity in Indian population for successful carrier detection
and for reducing the burden of hemophilia B among
Indians. The same may also hold for other populations
since the commonly used markers are reported to have
low heterozygosity in many of them [11,15,18]. How-
ever, in the best case scenario there will be a certain
proportion of obligate carriers left, who will still be
uninformative even with the use of these markers due
to the LD between different markers of F9 gene and di-
rect mutation detection will be the only way to perform
carrier detection in such cases.
The information content of the SNP markers in a
specific region of the genome is dependent on deter-
mined haplotype blocks based on linkage disequlilib-
rium between different markers. This has been best
demonstrated recently through the HAPMAP project
(http://www.hapmap.org/ [19]). However the project
does not include population groups from Indian sub-
continent, which makes our study relevant despite rel-
atively small size of samples as appropriate for this
part of the work. However the studies are underway
to decipher the landscape of genomic variation in In-
dian population [20], which will shed more light on the
utility of the commonly used markers for detection of
hemophilia B carriers.
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